WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo

WAKAMOTO PHARMACEUTICAL CO.,LTD.

Develops and sells pharmaceuticals, medical devices, and health foods.

4512 | T

Overview

Corporate Details

ISIN(s):
JP3991200001
LEI:
Country:
Japan
Address:
中央区日本橋本町二丁目2番2号

Description

WAKAMOTO PHARMACEUTICAL CO., LTD. is a company engaged in the research, development, production, and sale of pharmaceuticals. Its business encompasses both ethical (prescription) drugs and over-the-counter (OTC) products, as well as medical devices and health foods. The company specializes in therapeutic areas such as gastroenterology and is known as a pioneer in self-medication, with its flagship product being the nutrient-rich gastrointestinal remedy, "WAKAMOTO". The company actively manages a drug pipeline and engages in clinical trials to bring new therapeutic solutions to market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-11-13 01:54
確認書
Japanese ZIP 8.0 KB
2023-11-13 01:53
四半期報告書-第129期第2四半期(2023/07/01-2023/09/30)
Japanese ZIP 187.2 KB
2023-08-10 02:14
確認書
Japanese ZIP 8.0 KB
2023-08-10 02:12
四半期報告書-第129期第1四半期(2023/04/01-2023/06/30)
Japanese ZIP 146.1 KB
2023-06-28 06:22
内部統制報告書-第128期(2022/04/01-2023/03/31)
Japanese ZIP 21.7 KB
2023-06-28 06:22
確認書
Japanese ZIP 8.1 KB
2023-06-28 06:21
有価証券報告書-第128期(2022/04/01-2023/03/31)
Japanese ZIP 834.5 KB
2023-02-14 01:16
確認書
Japanese ZIP 8.0 KB
2023-02-14 01:15
四半期報告書-第128期第3四半期(2022/10/01-2022/12/31)
Japanese ZIP 154.9 KB
2022-11-14 02:14
四半期報告書-第128期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese ZIP 185.9 KB
2022-11-14 02:04
確認書
Japanese ZIP 8.1 KB
2022-08-10 02:10
確認書
Japanese ZIP 8.1 KB
2022-08-10 02:09
四半期報告書-第128期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese ZIP 151.4 KB
2022-06-24 04:07
内部統制報告書-第127期(令和3年4月1日-令和4年3月31日)
Japanese ZIP 21.7 KB
2022-06-24 04:07
確認書
Japanese ZIP 8.1 KB

Automate Your Workflow. Get a real-time feed of all WAKAMOTO PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WAKAMOTO PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WAKAMOTO PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.